- Insurers, PBMs and specialty pharmacies continue to integrate vertically, giving them more control over how and where drugs are accessed.
- Retail pharmacy growth continues to slow under increased competition, and the number of retail pharmacies continues to decrease.
- Rebates and discounts paid by manufacturers totaled $175 billion.
- Outside investors such as Amazon continue to look for new ways to disrupt how prescription drugs are dispensed.
© Arc, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to TMSalesOperations@arc-network.com. For more information visit Asset & Logo Licensing.